Physiomics Share News (PYC)

Physiomics Information

Buy PYC Shares
Add PYC to Watchlist
Add PYC to Alert

Share Price Information for Physiomics (PYC)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.30

Bid: 1.20

Ask: 1.40

Change: 0.00 (0.00%)

Spread: 0.20 (16.667%)

Open: 1.30

High: 1.30

Low: 1.30

Prev. Close: 1.30

Last checked at -

IN BRIEF: Physiomics wins deal to support client's oncology assets

Mon, 05th Feb 2024 11:21

Physiomics PLC - mathematical modelling company that supports oncology drug development - Wins further contract from existing client Numab Therapeutics AG. Says the project involves pharmacokinetic-pharmacodynamic modelling in support of one of Numab's oncology assets entering the clinic and will help inform dose and scheduling decisions. Chief Executive Officer Peter Sargent comments: "We are thrilled to have this opportunity to continue working with and supporting Numab on this asset through its preclinical stages as it heads into the clinic. Along with the project we announced with them in August 2023, this new project is testament to the continued support we provide and the great relationships we've built."

Current stock price: 1.50 pence, down 3.5%

12-month change: down 64%

By Greg Rosenvinge, Alliance News senior reporter

Comments and questions to newsroom@alliancenews.com

More News

12 Nov 2014 10:47

Physiomics Optimistic On Virtual Tumour Platform Interest

4 Nov 2014 12:10

UK MIDDAY BRIEFING: Oil Stocks Down As Oil Price Hits 4-Year Low

4 Nov 2014 11:32

UK WINNERS & LOSERS: Imperial Tobacco Gains As Oil Stocks Slide

4 Nov 2014 08:27

Physiomics Shares Jump On Disclosure Of Merck As Partner

4 Nov 2014 08:21

UK MORNING BRIEFING: Legal & General, Imperial Tobacco Start Strongly

27 Oct 2014 11:11

UK WINNERS & LOSERS: Banks Under Stress After EU Test Results

27 Oct 2014 10:16

Physiomics Extends Collaboration With "Major" Pharmaceutical Company

7 Oct 2014 08:51

Physiomics Launches Web-Based Cardiac Toxicity Prediction Service

14 Aug 2014 15:41

Physiomics wins cancer therapy deal

Biology company Physiomics won a contract with an unidentified drug company on Thursday, boosting its shares by 18.75%. Under the deal, Physiomics will model immune therapy agents for cancer research by the end of the year on a fee-for-service basis. Physiomics' chief executive Mark Shadwick said:

14 Aug 2014 12:20

Physiomics Wins Contract With Undisclosed Pharmaceutical Company

12 Jun 2014 12:24

Physiomics Shares Surge On Diatech Pharmacogenetics Collaboration

LONDON (Alliance News) - Shares in Physiomics PLC surged Thursday, after it said it has signed a head of terms agreement for a new collaboration with Diatech Pharmacogenetics srl. The Oxford-based systems biology company said that, under the terms of the expected collaboration agreement, th

10 Apr 2014 12:30

UK MIDDAY BRIEFING: Same Problems For M&S, WH Smith

LONDON (Alliance News) - Retailers Marks & Spencer and WH Smith Thursday reported better performances than of late, but still saw their shares decline as analysts worried that they still have a lot to do to fix their long-standing issues.

Marks

10 Apr 2014 10:57

UK WINNERS & LOSERS: M&S, WH Smith Drop Sharply After Early Strength

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices midday Thursday. ------- FTSE 100 - WINNERS ------- Resolution, up 1%. The firm said its insurance and pensions provider Friends Life is scrapping active member

10 Apr 2014 08:02

Physiomics To Show New Validation For Virtual Tumour Platform

LONDON (Alliance News) - Physiomics PLC said Thursday that it will be demonstrating a new validation of its Virtual Tumour Clinical Platform at a workshop in France, with a study that shows the platform can be used to make accurate predictions of clinical outcomes. The Virtual Tumour Clinic

3 Apr 2014 11:17

Physiomics In Talks With Pharmaceutical Companies For VTC Platform

LONDON (Alliance News) - Physiomics PLC said Thursday that it is in discussions with pharmaceutical companies about starting the first project to use its Virtual Tumour Clinical platform to predict outcomes for a new pipeline drug. It will be presenting the first validation of its Virtual T

Latest Share Chat

Physiomics Share News (PYC)

Share Price Information for Physiomics (PYC)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IN BRIEF: Physiomics wins deal to support client's oncology assets

Login to your account

Quickpicks are a member only feature

Login to your account